OncoPharma Middle East was established for the purpose of handling an entire block of business for pharmaceutical companies, supporting agents and distributers in this region, which is noted for its unique political, social, and economic environmentMany foreign and international companies find it difficult and impractical both logistically and financially to access and reach the markets in the Middle East as their strategic focus is elsewhere in the world. OncoPharma fills this gap by connecting such companies to the Gulf and Middle East, OncoPharma’s strengths include a team of professionals who speak the language of this region, know the markets and enjoy strong local partnerships, credibility, and links with the key healthcare partners in the Gulf and Middle East region.OncoPharma identifies innovative Biotechnology Pharmaceutical products from around the world specially approved by FDA and EMEA and introduces them to the region by identifying local partners and agents.OncoPharma focuses on products where we can compete and win only by quality, service, and value.
